Business · 28/07/2021
FDA Announces Draft Guidance for Olodaterol Hydrochloride; Tiotropium Bromide Inhalation Spray
The FDA has released a draft guidance document outlining product-specific recommendations for demonstrating bioequivalence to support abbreviated new drug applications for olodaterol hydrochloride; tiotropium bromide inhalation spray.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →